ID: ALA3629572

Max Phase: Preclinical

Molecular Formula: C12H15NO5S

Molecular Weight: 285.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCS(=O)(=O)c1ccc(C(=O)C[C@H](N)C(=O)O)cc1

Standard InChI:  InChI=1S/C12H15NO5S/c1-2-19(17,18)9-5-3-8(4-6-9)11(14)7-10(13)12(15)16/h3-6,10H,2,7,13H2,1H3,(H,15,16)/t10-/m0/s1

Standard InChI Key:  JLNPBBSGBIACRH-JTQLQIEISA-N

Associated Targets(non-human)

Kynurenine/alpha-aminoadipate aminotransferase 41 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 285.32Molecular Weight (Monoisotopic): 285.0671AlogP: 0.46#Rotatable Bonds: 6
Polar Surface Area: 114.53Molecular Species: ZWITTERIONHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 0.90CX Basic pKa: 8.56CX LogP: -2.38CX LogD: -2.41
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.73Np Likeness Score: -0.64

References

1. Dounay AB, Tuttle JB, Verhoest PR..  (2015)  Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway.,  58  (22): [PMID:26207924] [10.1021/acs.jmedchem.5b00461]
2. Pellicciari R, Liscio P, Giacchè N, De Franco F, Carotti A, Robertson J, Cialabrini L, Katsyuba E, Raffaelli N, Auwerx J..  (2018)  α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of De Novo Nicotinamide Adenine Dinucleotide (NAD+) Biosynthesis.,  61  (3): [PMID:29345930] [10.1021/acs.jmedchem.7b01254]

Source